| News
Former AbbVie executive Severino joins Flagship-backed startup as CEO
From BioPharma Dive
Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
Our mission is to cure disease by writing in the code of life.
Pioneering a new category of genetic medicine.
The first of its kind, Gene Writing technology can permanently make small and large alterations to the human genome.
No genetic disease target is off-limits. Our Gene Writers can make almost any type of genetic alteration.
Together, we’re driving the future of genetic medicine forward.
| News
Former AbbVie executive Severino joins Flagship-backed startup as CEO
From BioPharma Dive
| News
From Business Wire
| News
Tessera snags $300M+ for gene writing tech
From PitchBook